La determinación de P53 en tumor vesical primario infiltrante como factor pronóstico de subestadiaje
Mireía Musquera(Surgical Specialties (Canada)), H. Villavicencio Mavrich(Puigvert Foundation), F. Algaba Arrea(Universitat Autònoma de Barcelona), Juan Palou Redorta(Universitat Autònoma de Barcelona), Pietro Moscatiello(Universitat Autònoma de Barcelona), M.J. Ribal Caparrós(Hospital Clínic de Barcelona), J. Huguet Pérez, Ó. Rodríguez Faba(Puigvert Foundation)
Cited by 0
Related Papers
Robot-assisted Kidney Transplantation: The European Experience
|European Urology|2017|143
Feasibility of Transvaginal Natural Orifice Transluminal Endoscopic Surgery–Assisted Living Donor Nephrectomy: Is Kidney Vaginal Delivery the Approach of the Future?
|European Urology|2011|92
Utility of Fluorescence In Situ Hybridization as a Non-invasive Technique in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma
|European Urology|2006|87
Learning Curve in Robot-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group
|European Urology|2020|83
Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment
|British Journal of Urology|2012|81